Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 生命科學院
  3. 分子與細胞生物學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/28429
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor阮雪芬(Hsueh-Fen Juan)
dc.contributor.authorChing-Yao Shihen
dc.contributor.author施景耀zh_TW
dc.date.accessioned2021-06-13T00:08:02Z-
dc.date.available2012-08-01
dc.date.copyright2007-08-01
dc.date.issued2007
dc.date.submitted2007-07-27
dc.identifier.citation1. Agrawal, G. K., and J. J. Thelen. 2005. Development of a simplified, economical polyacrylamide gel staining protocol for phosphoproteins. Proteomics 5:4684-8.
2. Bosser, R., M. Faura, J. Serratosa, J. Renau-Piqueras, M. Pruschy, and O. Bachs. 1995. Phosphorylation of rat liver heterogeneous nuclear ribonucleoproteins A2 and C can be modulated by calmodulin. Mol Cell Biol 15:661-70.
3. Broxterman, H. J., and K. Hoekman. 1999. Direct activation of caspases by RGD-peptides may increase drug sensitivity of tumour cells. Drug Resist Updat 2:139-141.
4. Buchner, J. 1999. Hsp90 & Co. - a holding for folding. Trends Biochem Sci 24:136-41.
5. Buckley, C. D., D. Pilling, N. V. Henriquez, G. Parsonage, K. Threlfall, D. Scheel-Toellner, D. L. Simmons, A. N. Akbar, J. M. Lord, and M. Salmon. 1999. RGD peptides induce apoptosis by direct caspase-3 activation. Nature 397:534-9.
6. Caplan, A. J. 1999. Hsp9O’s secrets unfold: new insights from structural and functional studies. Trends Cell Biol 9:262-8.
7. Carpenter, B., C. MacKay, A. Alnabulsi, M. MacKay, C. Telfer, W. T. Melvin, and G. I. Murray. 2006. The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim Biophys Acta 1765:85-100.
8. Conroy, S. E., and D. S. Latchman. 1996. Do heat shock proteins have a role in breast cancer? Br J Cancer 74:717-21.
9. Erbas, B., E. Provenzano, J. Armes, and D. Gertig. 2006. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat
97:135-44.
10. Ferrer-Navarro, M., A. Gomez, 0. Yanes, R. Planell, F. X. Aviles, J. Pinol, J. A. Perez Pons, and E. Querol. 2006. Proteome of the bacterium Mycoplasma penetrans. J Proteome Res 5:688-94.
11. Frisch, S. M., and H. Francis. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619-26.
12. Fuller, K. J., R. D. Issels, D. 0. Slosman, J. G. Guillet, T. Soussi, and B. S. Polla.
1994. Cancer and the heat shock response. Eur J Cancer 30A:1884-91.
13. Gartner, T. K., and J. S. Bennett. 1985. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J Biol Chem 260:11891-4.
14. Guo, W., and F. G. Giancotti. 2004. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5:816-26.
15. Hopper, R. K., S. Carroll, A. M. Aponte, D. T. Johnson, S. French, R. F. Shen, F. A. Witzmann, R. A. Harris, and R. S. Balaban. 2006. Mitochondrial matrix phosphoproteome: effect of extra mitochondrial calcium. Biochemistry
45:2524-36.
16. Humphries, M. J. 2000. Integrin structure. Biochem Soc Trans 28:311-39.
1/. Hunter, 1. 2000. Slgnallng--200I) anti beyond. Cell 100:lli-2I.
18. Hynes, R. 0. 2002. Integrins: bidirectional, allosteric signaling machines. Cell
110:673-87.
19. Jemal, A., R. C. Tiwari, T. Murray, A. Ghafoor, A. Samuels, E. Ward, E. J. Feuer, and M. J. Thun. 2004. Cancer statistics, 2004. CA Cancer J Clin 54:8-29.
20. Juan, H. F., I. H. Wang, T. C. Huang, J. J. Li, S. T. Chen, and H. C. Huang.
2006. Proteomics analysis of a novel compound: cyclic RGD in breast carcinoma cell line MCF-7. Proteomics 6:2991-3000.
21. Kalume, U. E., H. Molina, and A. Pandey. 2003. Tackling the phosphoproteome: tools and strategies. Curr Opin Chem Biol 7:64-9.
22. Krecic, A. M., and M. S. Swanson. 1999. hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 11:363-71.
23. Kuhn, K., and J. Eble. 1994. The structural bases of integrin-ligand interactions. Trends Cell Biol 4:256-61.
24. Levine, A., F. Vannier, C. Absalon, L. Kuhn, P. Jackson, E. Scrivener, V. Labas, J. Vinh, P. Courtney, J. Garin, and S. J. Seror. 2006. Analysis of the dynamic Bacillus subtilis Ser/Thr/Tyr phosphoproteome implicated in a wide variety of cellular processes. Proteomics 6:2157-73.
25. Mankoff, U. 2005. Imaging in breast cancer - breast cancer imaging revisited. Breast Cancer Res 7:276-8.
26. Mayer, M. P., and B. Bukau. 1999. Molecular chaperones: the busy life of Hsp9O. Curr Biol 9:R322-5.
27. Nollen, E. A., and R. I. Morimoto. 2002. Chaperoning signaling pathways:
molecular chaperones as stress-sensing ‘heat shock’ proteins. J Cell Sci
115:2809-16.
28. O’Farrell, P. H. 1975. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250:4007-21.
29. Pearl, L. H., and C. Prodromou. 2000. Structure and in vivo function of Hsp9O. Curr Opin Struct Biol 10:46-51.
30. Pelham, H. R. 1986. Speculations on the functions of the major heat shock and glucose-regulated proteins. Cell 46:959-61.
31. Pierschbacher, M. U., and E. Ruoslahti. 1984. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309:30-3.
32. Plow, E. F., T. A. Haas, L. Zhang, J. Loftus, and J. W. Smith. 2000. Ligand binding to integrins. J Biol Chem 275:21785-8.
33. Plow, E. F., M. U. Pierschbacher, E. Ruoslahti, G. A. Marguerie, and M. H. Ginsberg. 1985. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci U S A
82:8057-61.
34. Price, L. 5. 1997. Morphological control of cell growth and viability. Bioessays
19:941-3.
35. Schmelzle, K., and F. M. White. 2006. Phosphoproteomic approaches to elucidate cellular signaling networks. Curr Opin Biotechnol 17:406-14.
36. Smith, U. F. 2000. Chaperones in progesterone receptor complexes. Semin Cell Dev Biol 11:45-52.
SI. Steinberg, 1. 1-1., B. J. Agnew, K. K. Uee, W. Y. Leung, 1. Uooaman, B.
Schulenberg, J. Hendrickson, J. M. Beechem, R. P. Haugland, and W. F.
Patton. 2003. Global quantitative phosphoprotein analysis using Multiplexed
Proteomics technology. Proteomics 3:1128-44.
38. Stern, D. F. 2001. Phosphoproteomics. Exp Mol Pathol 70:327-31.
39. Sulyok, G. A., C. Gibson, S. L. Goodman, G. Holzemann, M. Wiesner, and H. Kessler. 2001. Solid-phase synthesis of a nonpeptide RGD mimetic library: new selective alphavbeta3 integrin antagonists. J Med Chem 44:1938-50.
40. Tamkun, J. W., D. W. DeSimone, D. Fonda, R. S. Patel, C. Buck, A. F. Horwitz, and R. 0. Hynes. 1986. Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin. Cell 46:271-82.
41. Tockman, M. S., P. K. Gupta, J. D. Myers, J. K. Frost, S. B. Baylin, E. B. Gold, A. M. Chase, P. H. Wilkinson, and J. L. Mulshine. 1988. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J Clin Oncol
6: 1685-93.
42. Wasinger, V. C., S. J. Cordwell, A. Cerpa-Poljak, J. X. Yan, A. A. Gooley, M. R. Wilkins, M. W. Duncan, R. Harris, K. L. Williams, and I. Humphery-Smith. 1995. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 16:1090-4.
43. Zhao, Y. G., R. Gilmore, G. Leone, M. C. Coffey, B. Weber, and P. W. Lee.
2001. Hsp9O phosphorylation is linked to its chaperoning function. Assembly of the reovirus cell attachment protein. J Biol Chem 276:32822-7.
44. Zhou, J., D. C. Allred, I. Avis, A. Martinez, M. D. Vos, L. Smith, A. M. Treston, and J. L. Mulshine. 2001. Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNPA2/B1) in normal breast and neoplastic breast cancer. Breast Cancer Res Treat 66:217-24.
45. Zhou, J., J. L. Mulshine, J. Y. Ro, I. Avis, R. Yu, J. J. Lee, R. Morice, S. M. Lippman, and J. S. Lee. 1998. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers. Clin Cancer Res 4:1631-40.
46. Zitzmann, S., V. Ehemann, and M. Schwab. 2002. Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo. Cancer Res 62:5139-43.
SI. Steinberg, 1. 1-1., B. J. Agnew, K. K. Uee, W. Y. Leung, 1. Uooaman, B.
Schulenberg, J. Hendrickson, J. M. Beechem, R. P. Haugland, and W. F.
Patton. 2003. Global quantitative phosphoprotein analysis using Multiplexed
Proteomics technology. Proteomics 3:1128-44.
38. Stern, D. F. 2001. Phosphoproteomics. Exp Mol Pathol 70:327-31.
39. Sulyok, G. A., C. Gibson, S. L. Goodman, G. Holzemann, M. Wiesner, and H. Kessler. 2001. Solid-phase synthesis of a nonpeptide RGD mimetic library: new selective alphavbeta3 integrin antagonists. J Med Chem 44:1938-50.
40. Tamkun, J. W., D. W. DeSimone, D. Fonda, R. S. Patel, C. Buck, A. F. Horwitz, and R. 0. Hynes. 1986. Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin. Cell 46:271-82.
41. Tockman, M. S., P. K. Gupta, J. D. Myers, J. K. Frost, S. B. Baylin, E. B. Gold, A. M. Chase, P. H. Wilkinson, and J. L. Mulshine. 1988. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J Clin Oncol
6: 1685-93.
42. Wasinger, V. C., S. J. Cordwell, A. Cerpa-Poljak, J. X. Yan, A. A. Gooley, M. R. Wilkins, M. W. Duncan, R. Harris, K. L. Williams, and I. Humphery-Smith. 1995. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 16:1090-4.
43. Zhao, Y. G., R. Gilmore, G. Leone, M. C. Coffey, B. Weber, and P. W. Lee.
2001. Hsp9O phosphorylation is linked to its chaperoning function. Assembly of the reovirus cell attachment protein. J Biol Chem 276:32822-7.
44. Zhou, J., D. C. Allred, I. Avis, A. Martinez, M. D. Vos, L. Smith, A. M. Treston, and J. L. Mulshine. 2001. Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNPA2/B1) in normal breast and neoplastic breast cancer. Breast Cancer Res Treat 66:217-24.
45. Zhou, J., J. L. Mulshine, J. Y. Ro, I. Avis, R. Yu, J. J. Lee, R. Morice, S. M. Lippman, and J. S. Lee. 1998. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers. Clin Cancer Res 4:1631-40.
46. Zitzmann, S., V. Ehemann, and M. Schwab. 2002. Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo. Cancer Res 62:5139-43.
SI. Steinberg, 1. 1-1., B. J. Agnew, K. K. Uee, W. Y. Leung, 1. Uooaman, B.
Schulenberg, J. Hendrickson, J. M. Beechem, R. P. Haugland, and W. F.
Patton. 2003. Global quantitative phosphoprotein analysis using Multiplexed
Proteomics technology. Proteomics 3:1128-44.
38. Stern, D. F. 2001. Phosphoproteomics. Exp Mol Pathol 70:327-31.
39. Sulyok, G. A., C. Gibson, S. L. Goodman, G. Holzemann, M. Wiesner, and H. Kessler. 2001. Solid-phase synthesis of a nonpeptide RGD mimetic library: new selective alphavbeta3 integrin antagonists. J Med Chem 44:1938-50.
40. Tamkun, J. W., D. W. DeSimone, D. Fonda, R. S. Patel, C. Buck, A. F. Horwitz, and R. 0. Hynes. 1986. Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin. Cell 46:271-82.
41. Tockman, M. S., P. K. Gupta, J. D. Myers, J. K. Frost, S. B. Baylin, E. B. Gold, A. M. Chase, P. H. Wilkinson, and J. L. Mulshine. 1988. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J Clin Oncol
6: 1685-93.
42. Wasinger, V. C., S. J. Cordwell, A. Cerpa-Poljak, J. X. Yan, A. A. Gooley, M. R. Wilkins, M. W. Duncan, R. Harris, K. L. Williams, and I. Humphery-Smith. 1995. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 16:1090-4.
43. Zhao, Y. G., R. Gilmore, G. Leone, M. C. Coffey, B. Weber, and P. W. Lee.
2001. Hsp9O phosphorylation is linked to its chaperoning function. Assembly of the reovirus cell attachment protein. J Biol Chem 276:32822-7.
44. Zhou, J., D. C. Allred, I. Avis, A. Martinez, M. D. Vos, L. Smith, A. M. Treston, and J. L. Mulshine. 2001. Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNPA2/B1) in normal breast and neoplastic breast cancer. Breast Cancer Res Treat 66:217-24.
45. Zhou, J., J. L. Mulshine, J. Y. Ro, I. Avis, R. Yu, J. J. Lee, R. Morice, S. M. Lippman, and J. S. Lee. 1998. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers. Clin Cancer Res 4:1631-40.
46. Zitzmann, S., V. Ehemann, and M. Schwab. 2002. Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo. Cancer Res 62:5139-43.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/28429-
dc.description.abstract在許多配位分子中發現一種 integrin 的辨識區域,稱為 RGD motif。因此包含 RGD motif 的胜?可以和 integrin 受體結合,並進而引起細胞訊息的傳遞和影響許多疾病的過程。人工合成含有 RGD motif 的胜?已經廣泛被使用作為 ingegrin-ligand 相互作用的抑制劑,以進一步研究細胞的生長、死亡、附著、遷移和侵略。因此,我們設計了一個含有環狀 RGD 的胜? (Tpa-RGDWPC),有著更堅固的分子骨幹可以和受體緊密結合。根據之前的文獻報導指出,cRGD 可以誘導 MCF-7 乳癌細胞株的死亡。我們對於以 cRGD 處理 MCF-7 細胞的分子機制很有興趣。此外,因為後轉譯修飾的蛋白質磷酸化在細胞傳遞訊息中扮演極重要的角色,因此,我們使用蛋白質體學結合 Pro-Q Diamond 磷酸化蛋白染劑技術來作以 cRGD 處理過後的 MCF-7 細胞的整體性細胞蛋白觀察。在本次實驗中,我們找到一些磷酸化蛋白在 cRGD 誘導 MCF-7 細胞死亡中扮演重要角色,可做為一些治療乳癌的治療開發基礎。zh_TW
dc.description.abstractThe RGD (arginine-glycine-aspartate) motif is an integrin-recognition motif found in many ligands, so that RGD-containing peptides can interact with the integrin receptor to induce cell-signaling processes and influence many different diseases. Synthetic peptides containing the RGD motif have been used extensively as inhibitors of integrin-ligand interactions in studies of cell growth, death, adhesion, migration, and invasion. Therefore, we designed a cyclic-RGD peptide (Tpa-RGDWPC, cRGD) with rigid skeleton to closely bind with its receptor. According to previous reports that cRGD can cause cell death in MCF-7 breast cancer cell line. We are interested in what molecular mechanism underlies the cRGD exerts on MCF-7 cells. Depending on protein phosphorylation, it is a major post-translational modification connected to the signaling pathways in the cell. We used the proteomics with Pro-Q Diamond phosphoprotein dye technology to survey the global changes in phosphoproteins after cRGD treatment in MCF-7 cells. In this report, we find some phosphoproteins play important roles in cRGD treated MCF-7 cell death and provide a valuable in-depth insight into its use in breast cancer therapy.en
dc.description.provenanceMade available in DSpace on 2021-06-13T00:08:02Z (GMT). No. of bitstreams: 1
ntu-96-R94B43025-1.pdf: 17112140 bytes, checksum: 7042115596169b638ab66b3c09ed8d5e (MD5)
Previous issue date: 2007
en
dc.description.tableofcontents目錄口試委員審定書------------------------------ I
謝辭------------------------------11
摘要------------------------------111
Abstract ------------------------------ IV
圖目錄------------------------------ Vl
表目錄.------------------------------ Vl

第一章 文獻探討與研究動機 ------------------------------------------1
1.1 乳癌 (Breast cacner)---------------------------------------------1
1.2 整合素 (Integrin)-----------------------------------------------2
1.3 RGD 序列-----------------------------------------------------5
1.4 磷酸化蛋白質體學與 Pro-Q Diamond 磷酸化蛋白染色(Phosphoproteome and Pro-Q Diamond Phosphoprotein Stain)--------------------------------7
1.5 固相胜?合成法 (Solid Phase Peptide Synthesis)----------------------9
1.6 研究動機與目的------------------------------------------------10
第二章 實驗流程--------------------------------------------------13
2.1 實驗流程圖---------------------------------------------------13
第三章 實驗材料與方法---------------------------------------------14
3.1 固相胜?合成法------------------------------------------------14
3.2 逆相高效能液相層析分析-----------------------------------------21
3.3 人類乳癌細胞株 MCF-7 培養-------------------------------------22
3.4 MCF-7 細胞加藥處理-------------------------------------------24
3.5 蛋白質定量---------------------------------------------------25
3.7 二維 SDS-PAGE 電泳-------------------------------------------27
3.8 膠體蛋白水解 (In gel digestion)-----------------------------------28
第四章 實驗結果--------------------------------------------------29
4.1 cRGD 誘導人類乳癌細胞株 MCF-7 細胞凋亡-------------------------29
4.3 磷酸化蛋白質鑑定---------------------------------------------30
第五章 討論-----------------------------------------------------42
5.1 HSP90(Spot5)------------------------------------------------42
5.2 hnRNP A2/B1 (Spot 18)----------------------------------------42
第六章 結論及未來展望---------------------------------------------44
dc.language.isozh-TW
dc.subject整合素zh_TW
dc.subjectRGDzh_TW
dc.subject細胞死亡zh_TW
dc.subject磷酸化蛋白zh_TW
dc.subject乳癌zh_TW
dc.subjectIntegrinen
dc.subjectPhosphoproteinen
dc.subjectCell deathen
dc.subjectBreast canceren
dc.subjectRGDen
dc.title環狀 RGD 胜?誘導乳癌細胞株 MCF-7 細胞凋亡的磷酸化蛋白質探討zh_TW
dc.titlePhosphoproteome of cRGD-induced MCF-7 cell deathen
dc.typeThesis
dc.date.schoolyear95-2
dc.description.degree碩士
dc.contributor.oralexamcommittee黃宣誠(Hsuan-Cheng Huang),陳水田(Shui-Tein Chen)
dc.subject.keyword整合素,RGD,乳癌,細胞死亡,磷酸化蛋白,zh_TW
dc.subject.keywordIntegrin,RGD,Breast cancer,Cell death,Phosphoprotein,en
dc.relation.page60
dc.rights.note有償授權
dc.date.accepted2007-07-30
dc.contributor.author-college生命科學院zh_TW
dc.contributor.author-dept分子與細胞生物學研究所zh_TW
顯示於系所單位:分子與細胞生物學研究所

文件中的檔案:
檔案 大小格式 
ntu-96-1.pdf
  未授權公開取用
16.71 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved